|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
|---|---|
| Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
| ClinicalTrials.gov Identifier: | NCT00005295 |
Purpose
To determine risk factors for idiopathic pulmonary fibrosis.
| Condition |
|---|
|
Lung Diseases Pulmonary Fibrosis Lung Diseases, Interstitial |
| Study Type: | Observational |
| Study Design: | Natural History |
| Study Start Date: | July 1989 |
| Estimated Study Completion Date: | June 1995 |
BACKGROUND:
Idiopathic pulmonary fibrosis is a progressive and generally fatal disease that causes fibrosis of the pulmonary interstitium. While many environmental agents cause diseases clinically similar, the etiology of idiopathic pulmonary fibrosis suggests that environmental agents could incite the tissue injury that results in the disease; furthermore, host characteristics could have an important role in determining the magnitude of the host response to the agent initiating injury.
DESIGN NARRATIVE:
In this case control study, cases were ascertained at the multiple collaborating centers and controls were identified by telephone screening.
A telephone interview was conducted to collect information needed to test hypotheses concerning cigarette smoking, occupational exposure, indoor exposures, other environmental factors, and host factors. To limit disease misclassification, two pathologists experienced with interstitial diseases of the lung reviewed histopathological material from all cases to exclude entities other than interstitial lung fibrosis and to fully characterize the cases clinically. The mortality of this large series of cases was also described.
Eligibility| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
No eligibility criteria
Contacts and Locations
More Information
| Study ID Numbers: | 2018 |
| Study First Received: | May 25, 2000 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00005295 History of Changes |
| Health Authority: | United States: Federal Government |
|
Lung Diseases, Interstitial Respiratory Tract Diseases Fibrosis |
Idiopathic Pulmonary Fibrosis Lung Diseases Pulmonary Fibrosis |
|
Lung Diseases, Interstitial Pathologic Processes Respiratory Tract Diseases |
Fibrosis Lung Diseases Pulmonary Fibrosis |